Oncology Research

Papers
(The H4-Index of Oncology Research is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Galectins dysregulation: A way for cancer cells to invade and pervade36
Has_circ_0000069 expression in breast cancer and its influences on prognosis and cellular activities29
Long Noncoding RNA LAMTOR5-AS1 Interference Affects MicroRNA-506-3p/E2F6-Mediated Behavior of Non-Small Cell Lung Cancer Cells26
Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP125
Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer24
Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations22
lncCRLA Enhanced Chemoresistance in Lung Adenocarcinoma That Underwent EpithelialMesenchymal Transition21
Construction of the panoptosis-related gene model and characterization of tumor microenvironment infiltration in hepatocellular carcinoma21
Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany21
Long noncoding RNA TFAP2A AS1 exerts promotive effects in non small cell lung cancer progression via controlling the microRNA 548a 3p/CDK4 axis20
The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway19
System analysis based on the T cell exhaustion‑related genes identifies CD38 as a novel therapy target for ovarian cancer19
Prognostic-related genes for pancreatic cancer typing and immunotherapy response prediction based on single-cell sequencing data and bulk sequencing data18
Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis17
A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells17
Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms16
0.02397608757019